Glucose sensor monitoring for preventing DKA in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how a continuous glucose monitor affects diabetic ketoacidosis (DKA) risk. By tracking glucose levels closely, researchers hope to reduce dangerous complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 2 years old
- Have a type 1 diabetes diagnosis for at least 12 months
- Be willing to wear a glucose sensor and follow study instructions
- Provide informed consent (or parent/guardian consent plus assent for minors)
- No allergy to medical adhesives
- No other medical conditions or devices that could interfere (like pacemakers or dialysis)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different ways to monitor ketones (substances that can build up dangerously when your body lacks insulin) to lower the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes who also take SGLT-2 inhibitors (a type of diabetes drug). You'll wear a small sensor and follow a meal plan with carbs.
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
This study is testing a new wearable sensor that tracks both glucose (sugar) and ketone levels continuously. It might help people with type 1 diabetes manage their condition better and avoid complications.
This study looks at whether using a continuous glucose monitor (a small sensor that checks blood sugar levels around the clock) can help people who were just diagnosed with type 2 diabetes manage their blood sugar better. If you join, you would wear the sensor for a while and get regular feedback, which might help you learn how food and habits affect your sugar levels.
This study tests whether using a dual continuous glucose and ketone monitor can help people with type 1 diabetes safely take a class of drugs called SGLT2 inhibitors, which may improve blood sugar control but can increase the risk of diabetic ketoacidosis (DKA). By closely monitoring changes in glucose and ketone levels, the study aims to prevent dangerous episodes while benefiting from the drug's effects.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.